N = 488 | Â | Univariate analysis | Multivariate analysis | |
---|---|---|---|---|
Factor |  | P value | Co-ef +/− SD | P value |
Age | Â | 0.246* | Â | 0.925 |
Gender | Â | 0.012* | Â | 0.129 |
Pathology | Benign vs. Primary | 0.442 | Â | 0.144 |
 | Primary vs. Secondary | 0.226* |  | 0.878 |
Liver-directed chemotherapy | Â | 0.129* | Â | 0.219 |
Open or laparoscopic resection | Â | 0.009* | Â | 0.611 |
Radiofrequency ablation | Â | 0.191* | Â | 0.402 |
Wedge resection included | Â | <0.001* | Â | 0.086 |
Bile duct reconstruction | Â | 0.004* | Â | 0.651 |
Number of segments resected |  | <0.001* | 0.143 ± 0.012 | <0.001†|
Synchronous bowel procedure | Â | 0.516 | Â | Â |
Surgeon’s assessment of liver |  | <0.001* | 0.185 ± 0.042 | <0.001†|
Redo operation | 1st vs. 2nd resection | 0.268 | Â | Â |
 | 2nd vs. 3rd resection | 0.654 |  |  |
Pre-operative diabetes |  | <0.001* | 0.204 ± 0.064 | 0.002†|
Body mass index | Â | 0.06* | Â | 0.905 |
ASA grade | 1 vs. 2 | 0.014* | Â | 0.824 |
 | 2 vs. 3 | 0.709 |  | 0.872 |
P-POSSUM physiologic score | Â | 0.054* | Â | 0.221 |
Hepatic fibrosis/cirrhosis | Â | 0.667 | Â | Â |
Pre-operative bilirubin | Â | 0.320 | Â | Â |
Pre-operative haemoglobin | Â | 0.633 | Â | Â |
Neutrophil:lymphocyte ratio | Â | 0.400 | Â | Â |
Pre-operative albumin | Â | 0.399 | Â | Â |
Pre-operative alkaline phosphatase | Â | 0.014* | Â | 0.775 |
Pre-operative creatinine | Â | 0.392 | Â | Â |
Pre-operative glomerular filtration rate (GFR) >90 ml/min | Â | 0.042* | Â | 0.054 |
Blood loss (ml) | <500 vs. 500-999 | <0.001* | 0.131 ± 0.038 | 0.013†|
 | 500-999 vs. >1000 | 0.435 |  | 0.884 |
Units of red cells transfused |  | <0.001* | 0.043 ± 0.011 | <0.001†|